Drug Shortage Report for CESAMET
Report ID | 59693 |
Drug Identification Number | 02256193 |
Brand name | CESAMET |
Common or Proper name | CESAMET |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | NABILONE |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | n/a |
ATC code | A04AD |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2018-08-27 |
Estimated end date | |
Actual end date | 2018-11-26 |
Shortage status | Resolved |
Updated date | 2018-11-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2018-11-28 | French | Compare |
v6 | 2018-11-28 | English | Compare |
v5 | 2018-10-05 | French | Compare |
v4 | 2018-10-05 | English | Compare |
v3 | 2018-08-31 | French | Compare |
v2 | 2018-08-31 | English | Compare |
v1 | 2018-08-31 | English | Compare |
Showing 1 to 7 of 7